Microfluidic direct injection method for analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) using molecularly imprinted polymers coupled on-line with LC-MS/MS

J Pharm Biomed Anal. 2011 Jan 25;54(2):368-78. doi: 10.1016/j.jpba.2010.09.001. Epub 2010 Sep 15.

Abstract

The work described in this paper involves development of a high-throughput on-line microfluidic sample extraction method using capillary micro-columns packed with MIP beads coupled with tandem mass spectrometry for the analysis of urinary NNAL. The method was optimized and matrix effects were evaluated and resolved. The method enabled low sample volume (200 μL) and rapid analysis of urinary NNAL by direct injection onto the microfluidic column packed with molecularly imprinted beads engineered to NNAL. The method was validated according to the FDA bioanalytical method validation guidance. The dynamic range extended from 20.0 to 2500.0 pg/mL with a percent relative error of ±5.9% and a run time of 7.00 min. The lower limit of quantitation was 20.0 pg/mL. The method was used for the analysis of NNAL and NNAL-Gluc concentrations in smokers' urine.

MeSH terms

  • Adult
  • Butanols / urine*
  • Calibration
  • Chromatography, Liquid / methods
  • Female
  • Glucuronates / urine*
  • Humans
  • Male
  • Microfluidics / methods
  • Middle Aged
  • Molecular Imprinting
  • Molecular Structure
  • Molecular Weight
  • Nitrosamines / urine*
  • Online Systems
  • Polymers / chemistry*
  • Pyridines / urine*
  • Quality Control
  • Reference Standards
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods*
  • Time Factors

Substances

  • 4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid
  • Butanols
  • Glucuronates
  • Nitrosamines
  • Polymers
  • Pyridines